ADTX - Aditxt, Inc.
0.4746
0.008 1.601%
Share volume: 93,690
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$0.47
0.01
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-20-2024 | 08-19-2024 | 11-18-2024 | 05-15-2025 | 11-17-2025 | |
| Total revenue | 79.680 K | 44.276 K | 6.854 K | 1.018 K | 748.000 | |
| Cost of revenue | 65.799 K | 23.134 K | 467.536 K | 734.000 | 732.000 | |
| Gross profit | 13.881 K | 21.142 K | -460.682 K | 284.000 | 16.000 | |
| 52.31% | -2,278.99% | 100.06% | -94.37% | |||
| Operating expenses | 11.509 M | 5.973 M | 4.210 M | 5.557 M | 3.135 M | |
| Selling general and admin | 3.364 M | 4.420 M | 3.719 M | 4.348 M | 2.463 M | |
| Research and development | 8.145 M | 1.553 M | 491.552 K | 1.209 M | 672.045 K | |
| Total expenses | 11.550 M | 5.997 M | 4.240 M | 5.608 M | 3.141 M | |
| -48.07% | -29.29% | 32.26% | -44.00% | |||
| Operating income | -11.536 M | -5.976 M | -4.701 M | -5.608 M | -3.141 M | |
| Ebit | -11.744 M | -5.976 M | -4.701 M | -5.595 M | -23.631 M | |
| Pretax income | -14.869 M | -7.624 M | -6.980 M | -5.952 M | -24.208 M | |
| -48.73% | -8.44% | -14.72% | 306.68% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -14.869 M | -7.624 M | -6.980 M | -5.952 M | -24.208 M | |
| 48.73% | 8.44% | 14.72% | -306.68% |